Investment bank Compass Point downgraded Coinbase (ticker: COIN) from 'Neutral' to 'Sell', lowering its price target from $330 to $248, reflecting a 24.85% decrease. The downgrade is attributed to waning retail investor interest, increased competition in the stablecoin market, and concerns over the sustainability of Coinbase's valuation. Despite this, Coinbase shares have risen 28% year-to-date. The downgrade follows weaker-than-expected earnings, impacted by lower trading volumes. Following the downgrade, Coinbase shares fell 5.47% to $300.77, with option traders showing moderate bearish sentiment as the put/call ratio rose to 0.89. Other analyst updates include Barclays raising targets for companies such as Alphatec (ATEC) to $22, ATI to $90, and Avis (CAR) to $150, while Raymond James and Wells Fargo lowered targets for Aptar Group (ATR). JPMorgan increased price targets for BorgWarner (BWA) to $45 and HCA Healthcare (HCA) to $370. Piper Sandler raised Cheesecake Factory (CAKE) target to $62. In contrast, DA Davidson lowered BlueLinx (BXC) target to $75. Several other companies received target adjustments from various analysts, reflecting a mixed outlook across sectors.
$F -RBC raises Ford target to $11 from $10 Sector Perform - $FBLG -HC Wainwright raises FibroBiologics target to $12 from $10 Buy - $FLGT -UBS upgrades Fulgent Genetics to Buy from Neutral Raises target to $30 from $20 - $FSLR -UBS raises First Solar target to $275 from $255 Buy
$DENN -Piper lowers Denny’s target to $4 from $6 Neutral - $EA -Arete upgrades Electronic Arts to Buy from Neutral Raises target to $192 from $184 - $EMN -RBC lowers Eastman Chemical target to $74 from $91 Outperform - $ENR -UBS raises Energizer target to $29 from $23 Neutral -
$COST -Erste downgrades Costco to Hold from Buy - $CRSP -RBC raises CRISPR Therapeutics target to $42 from $38 Sector Perform - $CSCO -UBS raises Cisco Systems target to $74 from $70 Neutral - $CVRX -Cantor maintains CVRx $11 target Overweight -